120 related articles for article (PubMed ID: 17050250)
1. Ex vivo expansion of mafosfamide-purged PBPC products.
McNiece I; Civin C; Harrington J; Kellner J; Malehorn M; Turney J; Barber J; Jones R
Cytotherapy; 2006; 8(5):459-64. PubMed ID: 17050250
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504
[TBL] [Abstract][Full Text] [Related]
3. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
Andrews RG; Briddell RA; Hill R; Gough M; McNiece IK
Stem Cells; 1999; 17(4):210-8. PubMed ID: 10437984
[TBL] [Abstract][Full Text] [Related]
4. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
[TBL] [Abstract][Full Text] [Related]
5. Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells.
Fauth F; Martin H; Sonnhoff S; Bialleck H; Wiesneth M; Mihanovic B; Hoelzer D
Bone Marrow Transplant; 2000 Apr; 25(8):831-6. PubMed ID: 10808203
[TBL] [Abstract][Full Text] [Related]
6. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.
Levac K; Karanu F; Bhatia M
Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567
[TBL] [Abstract][Full Text] [Related]
7. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
[TBL] [Abstract][Full Text] [Related]
9. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma.
Decaudin D; Vantelon JM; Bourhis JH; Farace F; Bonnet ML; Guillier M; Greissenger N; Marracho MC; Assari S; Bennaceur AL; Némati F; Michon J; Turhan AG; Boccaccio C
Bone Marrow Transplant; 2004 Dec; 34(12):1089-93. PubMed ID: 15489877
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells.
McNiece I; Harrington J; Turney J; Kellner J; Shpall EJ
Cytotherapy; 2004; 6(4):311-7. PubMed ID: 16146883
[TBL] [Abstract][Full Text] [Related]
12. The plant mannose-binding lectin NTL preserves cord blood haematopoietic stem/progenitor cells in long-term culture and enhances their ex vivo expansion.
Li K; Ooi VE; Chuen CK; Lam AC; Ooi LS; Zhang XB; Tsang KS; Chiu LC; Chan KY; Li CK; Fok TF; Yuen PM; Ng PC
Br J Haematol; 2008 Jan; 140(1):90-8. PubMed ID: 17908183
[TBL] [Abstract][Full Text] [Related]
13. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
14. A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium.
Ivanovic Z; Duchez P; Dazey B; Hermitte F; Lamrissi-Garcia I; Mazurier F; Praloran V; Reiffers J; Vezon G; Boiron JM
Transfusion; 2006 Jan; 46(1):126-31. PubMed ID: 16398741
[TBL] [Abstract][Full Text] [Related]
15. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions.
Gunetti M; Ferrero I; Rustichelli D; Berger M; Gammaitoni L; Timeus F; Piacibello W; Aglietta M; Fagioli F
Exp Hematol; 2008 Feb; 36(2):235-43. PubMed ID: 18206730
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
[TBL] [Abstract][Full Text] [Related]
18. Purging of peripheral blood progenitor cell autografts and treatment of minimal residual disease.
Brugger W; Scheding S; Bock T; Ziegler B; Kanz L
Stem Cells; 1997; 15 Suppl 1():159-65. PubMed ID: 9368336
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model.
van Hensbergen Y; Schipper LF; Brand A; Slot MC; Welling M; Nauta AJ; Fibbe WE
Exp Hematol; 2006 Jul; 34(7):943-50. PubMed ID: 16797422
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis demonstrates expansion of SCID-repopulating cells and increased engraftment capacity in human cord blood following ex vivo culture with human brain endothelial cells.
Chute JP; Muramoto G; Fung J; Oxford C
Stem Cells; 2004; 22(2):202-15. PubMed ID: 14990859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
